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https://doi.org/10.In patients with atrial fibrillation (AF), left atrial (LA) fibrosis is a major determinant of
the progression to, and burden of AF. LA reservoir strain and total atrial conduction time
(PA-TDI) reflect LA fibrotic content. We aimed to investigate the relation between LA
reservoir strain and PA-TDI in AF patients and control subjects. Six-hundred two patients
(mean age 56 years, 53% men) with first episode of AF and 342 controls (mean age 64
years, 71% men) without structural heart disease underwent echocardiography. LA vol-
umes, PA-TDI, LA reservoir strain, and left ventricular global longitudinal strain (GLS)
were compared. Compared with controls, patients with paroxysmal AF and patients with
persistent AF had longer PA-TDI (128 § 25 millisecond, 140 § 31 millisecond, and 154 §
33 millisecond, respectively; p <0.001) and a progressive decline in LA reservoir strain
(36.9 § 11.6%, 29.8 § 13.4%, 24.2 § 12.3%, respectively; p <0.001). LA reservoir strain
was negatively correlated with PA-TDI (r = -0.43, p <0.001). On multivariate analyses,
LA reservoir strain, diabetes mellitus, and burden of AF were independent correlates of
PA-TDI (R2 = 0.23, p <0.001); whereas only PA-TDI was an independent correlate of LA
reservoir strain (R2 = 0.43, p <0.001); controlling for age, hypertension, coronary artery
disease, body mass index, severity of mitral regurgitation, left ventricular global longitudi-
nal strain, and LA volume. In conclusion, PA-TDI and LA reservoir strain are negatively
correlated in all subjects, irrespective of the presence or burden of AF. Patients with per-
sistent AF have longer PA-TDI and impaired LA reservoir strain compared with paroxys-
mal AF and controls, suggesting increasing burden of fibrosis and LA structural
remodeling in the progression of AF. © 2018 The Author(s). Published by Elsevier Inc.
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1016/j.amjcard.2018.04.047Atrial fibrillation (AF) leads to progressive structural
and functional changes in the left atrium (LA) over time.
LA fibrosis is a major determinant of the progression to,
and burden of AF and its substrate,13 leading to an
increase in total atrial activation time.4 The time delay
between the P-wave on the surface electrocardiogram
(ECG) and mechanical activation of the LA measured using
color-coded tissue Doppler echocardiography, the so-called
PA-TDI, provides a reliable estimate of total atrial activa-
tion time, reflecting the degree of atrial fibrosis on biopsy
specimens.5 LA compliance by echocardiographic LA res-
ervoir strain in AF patients has been shown to inversely
correlate with LA fibrosis burden demonstrated on late gad-
olinium contrast enhanced cardiac magnetic resonance.6
There is evidence of progressive remodeling of the LA
once AF develops with increasing fibrosis alongside lowerLA reservoir strain in patients with persistent AF compared
with patients with paroxysmal AF (PAF).6 However, the
relation between AF burden and LA reservoir strain and
PA-TDI is unknown. The present study investigated the
relation between AF burden and LA reservoir strain and
PA-TDI in patients with AF, and in control individuals with-
out structural heart disease. We hypothesized that increasing
AF burden is associated with more impaired LA reservoir
strain and longer total atrial activation time (PA-TDI).Methods
This retrospective case-control analysis included
patients presenting with their first episode of AF to our ter-
tiary referral center. Cases comprised patients in sinus
rhythm at the time of the echocardiogram. Echocardio-
grams performed within 3 weeks after cardioversion were
excluded to avoid the effects of atrial stunning. Patients
with congenital heart disease were excluded, as well as
patients without appropriate echocardiographic images for
measurement of PA-TDI.
Controls comprised subjects clinically referred for echo-
cardiography for the following indications: evaluation of
chest pain, palpitations, dyspnea, syncope, or preoperative
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if they had evidence of structural heart disease, or arrhyth-
mias that were documented on the cardiology department
and hospital information systems (EPD-Vision and EZIS;
Leiden University Medical Centre, Leiden, The Nether-
lands).
Demographic and anthropometric data, medication, tra-
ditional cardiac risk factors, co-morbidities, and New York
Heart Association functional class were collected. In accor-
dance with current European Society of Cardiology Guide-
lines, PAF was defined as self-terminating within 48 hours,
but may have continued up to 7 days; persistent AF was
defined as an episode lasting longer than 7 days or requir-
ing termination by either electrical or pharmacological car-
dioversion.7 AF burden was categorised as: “no AF,”
“paroxysmal AF,” and “persistent AF,” The Institutional
Review Board approved this retrospective analysis of clini-
cally acquired data and waived the need for patient written
informed consent.
Transthoracic echocardiography was performed with the
patient in the left lateral decubitus position using a commer-
cially available ultrasound transducer and equipment (3.5
Mhz or M5S probe, Vivid 7 and Vivid E9, GE-Vingmed,
Horten, Norway). All images were digitally stored for off-
line analysis (EchoPAC, version 113 1.1, GE-Vingmed,
Horten, Norway). All standard echocardiographic and
Doppler parameters of left ventricular (LV) systolic and
diastolic function were measured. The LV ejection fraction
was calculated using the Simpson’s biplane method of discs
as per current recommendations.8 Maximal LA volume was
measured in the apical 4-chamber view using Simpson’s
single plane method of discs.
Atrial tissue Doppler imaging (TDI). The PA-TDI dura-
tion was measured on color-coded TDI images of the LA
obtained in the apical 4-chamber view. The sector width
and depth were minimized to obtain the highest possible
frame rate. A fixed 9£ 9 pixel region of interest was
placed on the lateral LA wall, just above the mitral annulus,
to obtain the tracing of mechanical activation in that area.
The PA-TDI duration was obtained by measuring the time
delay between the onset of the P-wave on the surface ECG
and the peak of the A’-wave on the tissue Doppler tracing
(Figure 1).9
Strain imaging. Global longitudinal strain (GLS) of
the left ventricle was measured with 2-dimensional (2D)
speckle tracking echocardiography in the apical 4-, 2-
chamber and long-axis views using the highest possible
frame rates. LV GLS was calculated from the average
longitudinal strain curve of the 3 apical views. LA res-
ervoir strain was evaluated using 2D speckle tracking
on images obtained from the apical 4-chamber view.
Care was taken to avoid images with LA or LV fore-
shortening. LA reservoir strain was measured as the
peak longitudinal strain during ventricular systole
(Figure 2).10
Continuous variables were presented as mean § stan-
dard deviation for normally distributed variables, and
median (interquartile range) for non-Gaussian variables.
Continuous variables were compared with the unpaired Stu-
dent’s t-test, analysis of variance, and Wilcoxon rank sum
test, as appropriate. Categorical data are summarized asfrequencies and percentages, and compared using the chi-
square test. Multiple linear regression analysis was per-
formed to identify factors independently associated with
PA-TDI duration. Clinical and echocardiographic parame-
ters were chosen a priori based on biological plausibility,
published studies.6,1113 Parameters with p-values <0.2 on
univariate analysis were entered into the final multivariate
model as independent variables. Independent contribution
was assessed and there was no evidence of multicollinear-
ity. Case elimination was used for missing data. A 2-tailed
p-value <0.05 was considered statistically significant. Sta-
tistical analyses were performed using STATA v12
(STATA Corporation, Texas).Results
A total of 602 patients with AF and 342 controls with
complete echocardiographic examinations were included.
Clinical characteristics of AF patients compared with
controls are presented in Table 1. There were 364
patients with PAF and 238 patients with persistent AF.
Patients with AF were older and more frequently men,
with higher body mass index (BMI) and body surface
area compared with controls. A larger number of AF
patients had hypertension and dyslipidemia, and had
greater use of cardiac medications compared with con-
trols.
Echocardiographic parameters are presented in Table 2.
Patients with AF had increased LV wall thickness and
chamber size, with normal LV ejection fraction but
impaired GLS (-16.7 § 6.0%). Indexed LA volumes were
enlarged, and the LA reservoir strain was reduced in AF
patients. PA-TDI was significantly increased in patients
with AF compared with controls.
Compared with controls, patients with PAF and
patients with persistent AF showed a lengthening in PA-
TDI (128 § 25 millisecond, 140 § 31 millisecond, and
154 § 33 millisecond, respectively, p <0.001). On mul-
tivariate analysis, LA reservoir strain, diabetes mellitus,
and burden of AF (no AF, PAF, or persistent AF) were
independent correlates of PA-TDI when controlling for
age, hypertension, BMI, coronary artery disease, the
severity of mitral regurgitation, LV GLS, and LA vol-
ume (R2 = 0.23, p <0.001; Table 3).
Compared with controls, patients with PAF and patients
with persistent AF showed a progressive decline in LA res-
ervoir strain (36.9 § 11.6%, 29.8 § 13.4%, 24.2 § 12.3%,
respectively, p <0.001). On multivariate analysis, PA-TDI
was an independent correlate of LA reservoir strain when
controlling for age, hypertension, BMI, coronary artery dis-
ease, the severity of mitral regurgitation, LV GLS and LA
volume (R2 = 0.43, p <0.001; Table 4). The burden of AF
and diabetes mellitus were not significantly associated with
LA reservoir strain.
There was a significant linear relation between LA reser-
voir strain and PA-TDI in all subjects (r = -0.43, p <0.001)
such that impaired LA reservoir strain, indicating poor LA
compliance, was associated with prolonged PA-TDI. This
relation was maintained when controlling for the type of
AF (paroxysmal or persistent). To further assess the influ-
ence of the burden of AF on the relation between LA
Figure 1. Example of PA-TDI in a patient with PAF, and a control subject. The PA-TDI measurement was performed during sinus rhythm in both individu-
als. The PA-TDI duration is obtained by measuring the time delay between the onset of the P-wave on the surface ECG and the peak of the A’-wave on the tis-
sue Doppler tracing (time interval between the two dotted white lines, indicated by the white arrow). In this example, the control shown in panel (A) has a
short PA-TDI of 87 millisecond, in contrast to a prolonged PA-TDI of 210 millisecond in a patient with PAF.
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of 37% and mean PA-TDI of 128 millisecond of controls
were used as cut-off points (Figure 3). A larger proportion
of patients with persistent AF showed LA reservoir strain
less than 37% and PA-TDI longer than 128 millisecond
compared with patients with PAF (65% vs 51%, p = 0.001).
This demonstrates that increasing AF burden is associated
with more impaired LA reservoir strain and longer total
atrial activation time (PA-TDI).Discussion
The present study demonstrated that both the presence
and burden of AF were associated with morphofunctional
abnormalities of the left atrium, represented by larger LA
volumes, longer PA-TDI duration, and more impaired LA
reservoir strain. Our results also provide echocardiographic
evidence of a linear relation between total atrial conduction
time and atrial reservoir function in all subjects, irrespec-
tive of the presence or burden of AF.
Figure 2. Example of measurement of LA reservoir strain in a patient with AF, and a control subject. The LA reservoir strain measurement was performed
during sinus rhythm in both individuals. The LA endocardium is manually traced in the apical 4-chamber view, and region of thickness adjusted to the LA
wall. LA reservoir strain is measured as the peak global longitudinal strain during ventricular systole (white dotted curve, arrow). Panel (A) demonstrates nor-
mal LA reservoir strain of 57% in a control individual, and panel (B) shows reduced LA reservoir strain of 22% in a patient with PAF.
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cal, contractile, and structural remodeling of the left atrium
that plays a role in the persistency of the arrhythmia.14,15
The remodeling process that occurs within the atria culmi-
nates in the loss of atrial myocytes with increased collagen
content and consequent LA interstitial fibrosis.14 Hence,
fibrosis is considered a prime driver of AF, resulting in the
formation of micro re-entry circuits that may initiate and
perpetuate the atrial arrhythmia.16
Animal studies have demonstrated that AF is more likely
when atrial fibrosis is experimentally induced.17,18 In a
canine model, rapid atrial pacing was shown to result in a
fourfold release of collagen-I and fibronectin-I from cardiac
myocytes in atrial tissue that caused structural remodeling
by altering cardiac fibroblast function, and contributed to
the upregulation of extracellular matrix genes.19
Fibrosis, demonstrated on postmortem biopsy speci-
mens, has been related to the burden of AF independent of
age, with control patients exhibiting no significant fibrosis.1Clinical studies examining histological biopsies have dem-
onstrated increased fibrosis in patients with AF,20 the
higher atrial fibrotic content was associated with the occur-
rence of AF after cardiac bypass surgery,21 and the success
of Maze ablation.20,22 The extent of atrial fibrosis, demon-
strated on late gadolinium enhancement cardiac magnetic
resonance, has also been related to the burden of AF in
some studies, whilst other have shown that the degree of
structural remodeling is independent of AF type and co-
morbidities.6,23,24 Regardless of the relation with AF bur-
den, the degree of fibrosis on late gadolinium contrast
enhanced cardiac magnetic resonance in these studies was
shown to be a predictor of ablation success.3,23,24
The PA-TDI duration on TDI echocardiography meas-
ures the total atrial activation time, and is a novel noninva-
sive surrogate for fibrosis.5 Longer PA-TDI has been
demonstrated alongside higher degrees of atrial fibrosis on
biopsy specimens in patients who develop new-onset AF
after cardiac surgery compared with those who remain in
Table 1
Clinical characteristics of controls and atrial fibrillation patients
Characteristic Controls (n = 342) Atrial fibrillation patients (n = 602) p value
Age (years) 56 § 16 64 § 12 <0.001
Men 180 (53%) 429 (71%) <0.001
Body mass index (kg/m2) 26 § 4 27 § 5 <0.001
Body surface area, /m2 1.91 § 0.21 2.03 § 0.24 <0.001
Hypertension 122 (36%) 411 (68%) <0.001
Current smoker 31 (9%) 80 (13%) 0.073
Dyslipidemia 63 (18%) 294 (49%) <0.001
Diabetes mellitus 39 (11%) 87 (14%) 0.175
Medications:
Aspirin or clopidogrel 0 137 (23%)
Anticoagulant (warfarin or novel oral anticoagulant) 0 377 (63%)
Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker 80 (23%) 334 (56%) <0.001
Calcium channel blocker 28 (8%) 128 (21%) <0.001
Beta-blocker 60 (18%) 402 (67%) <0.001
Amiodarone 0 48 (8%)
Diuretic 50 (15%) 194 (32%) <0.001
Aldosterone antagonist 0 53 (9%)
Statin 68 (20%) 268 (45%) <0.001
Dyslipidemia was defined as previously diagnosed dyslipidemia, treatment with lipid-lowering agents, low-density lipoprotein 3.0 mmol/L in low-to-
moderate risk groups, 2.6 mmol/L in high-risk groups, and 1.8 mmol/L in very high-risk groups.
Table 2
Echocardiographic characteristics of controls compared with atrial fibrillation patients
Variable Controls (n = 342) Atrial fibrillation patients (n = 602) p value
Interventricular septal thickness (mm) 10 § 2 12 § 3 <0.001
Left ventricular end diastolic diameter (mm) 48 § 6 50 § 8 0.006
Posterior wall thickness (mm) 10 § 2 11 § 2 <0.001
Left ventricular end-systolic diameter 31 § 6 32 § 9 0.003
Left atrial dimension (mm) 35 § 5 43 § 7 <0.001
Left ventricular end-diastolic volume (ml) 103 (40) 116 (53) <0.001
Left ventricular end-systolic volume (ml) 41 (24) 49 (30) <0.001
Left ventricular ejection fraction, % 60 (11) 57 (14) <0.001
Left atrial volume indexed (ml/m2) 24 § 8 43 § 18 <0.001
Left ventricular global longitudinal systolic strain, % ¡18.5 (2.6) ¡16.7 (6.0) <0.001
Left atrial reservoir strain, (%) 36.9 § 11.6 27.6 § 13.3 <0.001
PA-TDI (millisecond) 128 § 25 146 § 32 <0.001
Table 3
Univariate and multivariate linear regression examining correlates of PA-TDI
Variable Univariate Multivariate model (R2 = 0.23, p <0.001)
Coefficient 95% confidence interval p value Coefficient 95% confidence interval p value
Age (years) 0.92 0.79  1.05 <0.001 0.63 0.41  0.85 <0.001
History of hypertension 10.02 6.09  13.96 <0.001 ¡3.62 ¡8.9  1.67 0.180
Diabetes mellitus 11.17 5.40  16.94 <0.001 8.28 1.26  15.31 0.021
Coronary artery disease 19.45 14.83  24.08 <0.001 3.43 ¡2.03  8.89 0.218
Body mass index (kg/m2) 0.73 0.29  20.25 0.001 0.04 ¡0.5  0.57 0.895
Atrial fibrillation burden 13.02 10.61  15.43 <0.001 6.99 2.05  11.93 0.006
Mitral regurgitation grade 5.30 1.24  9.35 0.011 ¡0.88 ¡4.75  2.99 0.656
Left atrial volume indexed (ml/m2) 0.59 0.48  0.69 <0.001 0.17 0.02  0.31 0.026
Left ventricular global longitudinal strain (%) 1.70 1.23  2.17 <0.001 ¡0.17 ¡0.77  0.43 0.575
Left atrial reservoir strain, (%) ¡0.98 ¡1.12  0.85 <0.001 ¡0.58 ¡0.81  0.36 <0.001
Constant 94.80 85.96  121.06 <0.001
Atrial fibrillation burden categorized as: “no AF,” “paroxysmal AF,” and “persistent AF.”
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Table 4
Univariate and multivariate linear regression examining correlates of LA reservoir strain
Variable Univariate Multivariate model (R2 = 0.43, p<0.001)
Coefficient 95% confidence interval p value Coefficient 95% confidence interval p value
Age (years) ¡0.36 ¡0.41  0.30 <0.001 ¡0.16 ¡0.24  0.08 0.000
History of hypertension ¡4.82 ¡6.53  3.11 <0.001 0.66 ¡1.21  2.53 0.490
Diabetes mellitus ¡2.89 ¡5.42  0.36 0.025 1.13 ¡1.36  3.62 0.372
Coronary artery disease ¡10.46 ¡12.43  8.49 <0.001 ¡1.23 ¡3.16  0.70 0.210
Body mass index (kg/m2) ¡0.48 ¡0.67  0.29 <0.001 ¡0.19 ¡0.38  0.01 0.043
Atrial fibrillation burden ¡6.38 ¡7.41  5.35 <0.001 ¡0.02 ¡1.77  1.74 0.985
Mitral regurgitation grade ¡3.28 ¡4.95  1.62 <0.001 0.59 ¡0.78  1.95 0.399
Left atrial volume indexed (ml/m2) ¡0.36 ¡0.40  0.32 <0.001 ¡0.24 ¡0.29  0.2 0.000
PA-TDI (millisecond) ¡0.19 ¡0.21  0.16 <0.001 ¡0.07 ¡0.10  0.04 0.000
Left ventricular global longitudinal strain (%) ¡1.46 ¡1.64  1.27 <0.001 ¡1.06 ¡1.25  0.86 0.000
Constant 47.17 38.07  56.28 0.000
Atrial fibrillation burden categorized as: “no AF,” “paroxysmal AF,” and “persistent AF.”
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sinus rhythm, on the ECG to measure this interval, how-
ever, limits its use during AF. Nonetheless, the value of
PA-TDI in predicting new-onset AF and the success of
radiofrequency catheter ablation has been previously dem-
onstrated.9,26 We demonstrated that the burden of AF and
co-morbidities is related to the degree of structural remod-
eling as represented by the PA-TDI duration, and is in sup-
port of the previously mentioned invasive and noninvasive
studies. Furthermore, they reinforce the feasibility of this
noninvasive echocardiographic technique for atrial sub-
strate evaluation.
The imbalance in collagen synthesis and degradation
leading to myolysis and the development of a fibrotic atrial
substrate has consequent effects on LA electromechanical
function, manifest as longer atrial conduction times and
reduced atrial compliance and contractility.27,28 LA reser-
voir strain represents LA relaxation and lengthening during
ventricular systole and is an indicator of LA compliance.
We proposed that remodeling of the atrial substrate and
increasing fibrosis may reduce LA compliance during theFigure 3. Relation between LA reservoir strain and PA-TDI in patients with parox
relation between LA reservoir strain and PA-TDI, the mean LA reservoir strain of
points. There were more patients (65%) in the persistent AF group that had LA re
pared with 51% of patients in the PAF group (p = 0.001).LA reservoir phase. A previous study has demonstrated a
relation between LA reservoir strain and the degree of
fibrosis on late gadolinium contrast enhanced cardiac mag-
netic resonance that was evident in patients with persistent
but not in patients with PAF, and the authors proposed that
LA reservoir strain is a surrogate for fibrosis.6 Our study
confirmed the hypothesis that LA compliance is impaired
in AF, and together with the significant negative relation
with PA-TDI, suggests that these changes may be due to
atrial fibrosis. We believe this also explains the relation in
the previously mentioned study, that LA reservoir strain is
reduced as a functional consequence of the structural
remodeling that prolongs electrical, and therefore, mechani-
cal activation of the LA. These improved mechanistic
insights may lead to innovative and improved therapeutic
approaches for rhythm control in patients with AF.
To our knowledge, the present study is the first to dem-
onstrate this relation between PA-TDI and LA reservoir
strain in AF patients, providing a better understanding of
the relation between structure and function. Additionally,
this is the first study to evaluate PA-TDI in a controlysmal and persistent AF. To assess the influence of the burden of AF on the
37% and mean PA-TDI of 128 millisecond of controls were used as cut-off
servoir strain less than 37% and PA-TDI higher than 128 millisecond, com-
590 The American Journal of Cardiology (www.ajconline.org)population and, beyond that, to show that the relation with
LA reservoir strain exists even in patients without AF. It is
important to note that this study is subject to the inherent
limitations of an observational study. Future prospective
studies are required to establish reference ranges and evalu-
ate determinants of PA-TDI in a control population; deter-
mine the applications, if any, of this noninvasive tool in
non-AF populations; as well as examine the utility and ther-
apeutic implications of LA reservoir strain and PA-TDI in
predicting overall AF burden and conversion of paroxysmal
to persistent AF.
In conclusion, total atrial conduction time (PA-TDI) and
LA reservoir strain are negatively correlated in all subjects,
irrespective of the presence or burden of AF. Patients with
persistent AF have longer PA-TDI and impaired LA reser-
voir strain compared with PAF and controls, suggesting
increasing burden of fibrosis and LA structural remodeling
in the progression of AF.Disclosures
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